Subject
Pharmacology (medical),Pharmacology
Reference62 articles.
1. Maheu E, Bannuru RR, Herrero-Beaumont G, Allali F, Bard H, Migliore A. Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review - Seminars in Arthritis and Rheumatism, 2019; 48(4):563-572, doi:10.1016/j.semarthrit.2018.06.002.
2. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to anti-rheumatic drug therapy in patients with of the hip or knee;Bellamy;J Rheumatol,1988
3. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited;Pham;Osteoarthritis and Cartilage,2004
4. Minimal Perceptible Clinical Improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessment in patients with osteoarthritis;Ehrich;J Rheumatol,2000
5. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献